Imunon/$IMNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Imunon
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
Ticker
$IMNN
Sector
Primary listing
Employees
25
Headquarters
Website
Imunon Metrics
BasicAdvanced
$11m
-
-$6.83
2.12
-
Price and volume
Market cap
$11m
Beta
2.12
52-week high
$41.22
52-week low
$2.52
Average daily volume
153k
Financial strength
Current ratio
2.319
Quick ratio
1.899
Long term debt to equity
8.53
Total debt to equity
14.285
Profitability
EBITDA (TTM)
-14.359
Management effectiveness
Return on assets (TTM)
-83.22%
Return on equity (TTM)
-256.41%
Valuation
Price to book
1.36
Price to tangible book (TTM)
1.36
Price to free cash flow (TTM)
-0.419
Free cash flow yield (TTM)
-238.46%
Free cash flow per share (TTM)
-6.677
Growth
Earnings per share change (TTM)
-59.71%
3-year earnings per share growth (CAGR)
-52.95%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Imunon stock?
Imunon (IMNN) has a market cap of $11M as of May 04, 2026.
What is the P/E ratio for Imunon stock?
The price to earnings (P/E) ratio for Imunon (IMNN) stock is 0 as of May 04, 2026.
Does Imunon stock pay dividends?
No, Imunon (IMNN) stock does not pay dividends to its shareholders as of May 04, 2026.
When is the next Imunon dividend payment date?
Imunon (IMNN) stock does not pay dividends to its shareholders.
What is the beta indicator for Imunon?
Imunon (IMNN) has a beta rating of 2.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.